# Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients

> **NCT01382199** · PHASE3 · UNKNOWN · sponsor: **Ventria Bioscience** · enrollment: 340 (estimated)

## Conditions studied

- Diarrhea

## Interventions

- **DRUG:** Lactoferrin

## Key facts

- **NCT ID:** NCT01382199
- **Lead sponsor:** Ventria Bioscience
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-09
- **Primary completion:** 2013-09
- **Final completion:** 2014-03
- **Target enrollment:** 340 (ESTIMATED)
- **Last updated:** 2011-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01382199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01382199, "Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01382199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*